Home › Stocks › ANIP › All Fund Holders
ANIP — ANI PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 43 · Reported value held: $575.01M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 1.31M | $103.02M | 0.00% | Add |
| Point72 Asset Management history | Q2 2026 | 47.85M | $62.02M | 0.07% | Add |
| Arrowstreet Capital history | Q2 2026 | 562.02K | $46.52M | 0.02% | Hold |
| Geode Capital Management history | Q2 2026 | 536.41K | $44.41M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 507.21K | $41.99M | 0.02% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 323.44K | $26.77M | 0.01% | Add |
| Invesco Ltd history | Q2 2026 | 309.23K | $25.60M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 297.54K | $24.63M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 252.57K | $20.91M | 0.00% | Add |
| BlackRock Inc history | Q2 2026 | 15.06M | $19.51M | 0.00% | Add |
| Balyasny Asset Management history | Q1 2026 | 15.00M | $18.64M | 0.03% | Add |
| Northern Trust Corp history | Q2 2026 | 209.16K | $17.31M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 183.07K | $15.15M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 174.73K | $14.46M | 0.01% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 9.30M | $12.22M | 0.00% | New |
| Principal Global Investors history | Q2 2026 | 134.15K | $11.11M | 0.01% | Add |
| Goldman Sachs Group history | Q2 2026 | 6.97M | $9.03M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 104.78K | $8.67M | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 109.55K | $8.42M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 64.23K | $5.32M | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2026 | 63.70K | $5.27M | 0.01% | Reduce |
| PSP Investments history | Q2 2026 | 62.62K | $5.18M | 0.01% | Reduce |
| Citigroup Inc history | Q2 2026 | 3.58M | $4.64M | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 45.08K | $3.73M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 36.85K | $3.05M | 0.00% | Add |
| Amundi US history | Q2 2026 | 31.79K | $2.63M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 31.39K | $2.60M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 29.50K | $2.44M | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 19.25K | $1.59M | 0.00% | Reduce |
| Royce & Associates history | Q2 2026 | 18.42K | $1.52M | 0.01% | Reduce |
| Maverick Capital history | Q2 2024 | 18.54K | $1.18M | 0.02% | Add |
| Manulife Financial history | Q2 2026 | 10.69K | $884.75K | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 650.00K | $845.11K | 0.00% | Reduce |
| Norges Bank Investment Management history | Q2 2026 | 9.59K | $793.45K | 0.00% | Hold |
| Wellington Management Group history | Q2 2026 | 7.05K | $583.43K | 0.00% | Reduce |
| CPP Investments history | Q2 2026 | 6.60K | $546.35K | 0.00% | Reduce |
| Polen Capital Management history | Q1 2026 | 6.41K | $492.85K | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 337.00K | $436.48K | 0.00% | Hold |
| Marshall Wace history | Q4 2025 | 5.52K | $435.59K | 0.00% | Reduce |
| Franklin Resources history | Q2 2026 | 4.02K | $333.02K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 1.08K | $89.15K | 0.00% | Add |
| Lazard Asset Management history | Q2 2026 | 351.00K | $4.55K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 17.10K | $1.42K | 0.00% | Add |